Author:
Yu Gaoxiang,Ding Jian,Yang Ningning,Ge Lu,Chen Nuo,Zhang Xuzi,Wang Qiuchen,Liu Xian,Zhang Xuanlong,Jiang Xiaoqiong,Geng Yibo,Zhang Chenxi,Pan Jiadong,Wang Xiangyang,Gao Weiyang,Li Zhijie,Zhang Hongyu,Ni Wenfei,Xiao Jian,Zhou Kailiang,Yang Liangliang
Abstract
AbstractIn the realm of large-area trauma flap transplantation, averting ischaemic necrosis emerges as a pivotal concern. Several key mechanisms, including the promotion of angiogenesis, the inhibition of oxidative stress, the suppression of cell death, and the mitigation of inflammation, are crucial for enhancing skin flap survival. Apoptotic bodies (ABs), arising from cell apoptosis, have recently emerged as significant contributors to these functions. This study engineered three-dimensional (3D)-ABs using tissue-like mouse adipose-derived stem cells (mADSCs) cultured in a 3D environment to compare their superior biological effects against 2D-ABs in bolstering skin flap survival. The findings reveal that 3D-ABs (85.74 ± 4.51) % outperform 2D-ABs (76.48 ± 5.04) % in enhancing the survival rate of ischaemic skin flaps (60.45 ± 8.95) % (all p < 0.05). Mechanistically, they stimulated angiogenesis, mitigated oxidative stress, suppressed apoptosis, and facilitated the transition of macrophages from M1 to M2 polarization (all p < 0.05). A comparative analysis of microRNA (miRNA) profiles in 3D- and 2D-ABs identified several specific miRNAs (miR-423-5p-up, miR30b-5p-down, etc.) with pertinent roles. In summary, ABs derived from mADSCs cultured in a 3D spheroid-like arrangement exhibit heightened biological activity compared to those from 2D-cultured mADSCs and are more effective in promoting ischaemic skin flap survival. These effects are attributed to their influence on specific miRNAs.
Funder
Natural Science Foundation of Zhejiang Province
Natural Science Foundation of Ningbo
Wenzhou Science and Technology Innovation Project
National Natural Science Foundation of China
Zhejiang Provincial Medical and Health Science Foundation of China
Publisher
Springer Science and Business Media LLC